Aurinia Pharmaceuticals to Acquire Kezar Life Sciences for $6.955 in Cash per Share Plus a Contingent Value Right
Go back to Aurinia Pharmaceuticals to Acquire Kezar Life Sciences for $6.955 in Cash per Share Plus a Contingent Value Right| (NASDAQ: AUPH) | Delayed: 17.88 +0.35 (2.00%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.53 | 52 Week High | $5.69 | |||
| Open | $17.39 | 52 Week Low | $1.42 | |||
| Day High | $18.05 | P/E | N/A | |||
| Day Low | $17.07 | EPS | $0.00 | |||
| Volume | 2,184,109 | |||||
| (NASDAQ: KZR) | Delayed: 7.29 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.29 | 52 Week High | $ | |||
| Open | $7.29 | 52 Week Low | $ | |||
| Day High | $7.29 | P/E | N/A | |||
| Day Low | $7.29 | EPS | $ | |||
| Volume | 294,533 | |||||
